Cost–Utility Analysis of a Latanoprost Cationic Emulsion (STN1013001) versus Other Latanoprost in the Treatment of Open-Angle Glaucoma or Ocular Hypertension and Concomitant Ocular Surface Disease in Germany-Reference-Cited by-同舟云学术

Cost–Utility Analysis of a Latanoprost Cationic Emulsion (STN1013001) versus Other Latanoprost in the Treatment of Open-Angle Glaucoma or Ocular Hypertension and Concomitant Ocular Surface Disease in Germany

Published:2022-02 Issue: Volume:Volume 16 Page:323-337
ISSN:1177-5483
Container-title:Clinical Ophthalmology
language:en
Short-container-title:OPTH

Author:

Lazzaro Carlo,van Steen Cécile,Billeit Stephan,Frauenknecht Heinrich,Kallen Christopher,Pfennigsdorf Stefan,Thelen Ulrich,Angelillo Luigi

Publisher

Informa UK Limited

Subject

Ophthalmology

Reference54 articles.

1. Prevalence, incidence, and risk factors of primary open-angle glaucoma - a cohort study based on longitudinal data from a German public health insurance

2. Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040

Current Knowledge and Attitudes Concerning Cost-Effectiveness in Glaucoma Pharmacotherapy: A Glaucoma Specialists Focus Group Study

4. Direct cost and predictive factors for treatment in patients with ocular hypertension or early, moderate and advanced primary open-angle glaucoma: the CoGIS study in Germany

5. Direct costs of glaucoma and severity of the disease: a multinational long term study of resource utilisation in Europe

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of a Preservative-Free Latanoprost Cationic Emulsion in Patients with Open-Angle Glaucoma and Concurrent Ocular Surface Disease: A Randomized Phase 2 Study;Journal of Ocular Pharmacology and Therapeutics;2024-08-16

2. Letter to the Editor: Lazzaro responds to Kennedy et al.;The European Journal of Health Economics;2024-06-25

3. Systematic methodological review of health state values in glaucoma cost-utility analyses;The European Journal of Health Economics;2024-02-27

4. A latanoprost cationic emulsion (STN1013001) vs. other latanoprost formulations (Latanoprost) in open angle glaucoma/ocular hypertension and ocular surface disease: an Italian cost-utility analysis;Expert Review of Pharmacoeconomics & Outcomes Research;2023-01-09